Institutional Ownership Monte Rosa Therapeutics, Inc. (GLUE)
This table provides information about the institutional ownership of Monte Rosa Therapeutics, Inc. (GLUE). We have compiled data on the 108 institutions that hold shares in the stock, with a total of 53.6 Million shares, which have been reported (via 13F filing form) to have a value of $304 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Gamma Investing LLC
Foster City, CA |
Jul 14, 2025 Q2 2025 |
80
shares
|
$452
0.0% of portfolio
|
Q2 2025
Reduced 93.49%
|
|
|
Pnc Financial Services Group, Inc.
Pittsburgh, PA |
May 09, 2025 Q1 2025 |
66
shares
|
$373
0.0% of portfolio
|
Q1 2025
Added 135.71%
|
|
|
Rothschild Investment LLC
Chicago, IL |
Apr 08, 2025 Q1 2025 |
50
shares
|
$283
0.0% of portfolio
|
Q1 2025
Reduced 58.33%
|
|
|
True Wealth Design, LLC
Akron, OH |
May 13, 2025 Q1 2025 |
23
shares
|
$130
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
New holding
|